Enliven Therapeutics, Inc. - COM (ELVN)

Historical Portfolio Holders from Q1 2023 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
44.5M
Holdings value Q1 2024
$781M
Value change Q1 2024
+$95.2M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
72
Number of buys Q1 2024
65
Number of sells Q1 2024
-24
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 48.3M $1.13B +$91.1M $23.37 90
2024 Q1 44.5M $781M +$95.2M $17.59 72
2023 Q4 39M $540M -$653K $13.84 61
2023 Q3 39.1M $534M -$2.18M $13.66 61
2023 Q2 39.1M $798M +$113M $20.41 61
2023 Q1 33.6M $735M +$735M $21.90 44